Dual Regulation of miR-34a and Notch Signaling in Triple-Negative Breast Cancer by Antibody/miRNA Nanocarriers

Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that lacks expression of the three most common receptors present on other subtypes, leaving it unsusceptible to current targeted or hormonal therapies. In this study, we introduce an alternative treatment strategy for TNB...

Descripción completa

Detalles Bibliográficos
Autores principales: Valcourt, Danielle M., Day, Emily S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332498/
https://www.ncbi.nlm.nih.gov/pubmed/32622330
http://dx.doi.org/10.1016/j.omtn.2020.06.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332498/
https://www.ncbi.nlm.nih.gov/pubmed/32622330
http://dx.doi.org/10.1016/j.omtn.2020.06.003

Ejemplares similares